Federal Executive Order: Enhancing Access to Medical Marijuana in Medicare
Discover how recent federal changes will expand Medicare access to hemp-derived cannabinoid products and the implications for the insurance industry.
2027 Medicare Advantage Proposal Expands Coverage to Include Select Hemp Products
CMS proposes expanded 2027 Medicare Advantage benefits to include FDA-approved hemp products as supplemental coverage for chronically ill enrollees, following federal and state hemp regulations.
CMS Proposes Medicare Coverage for CBD Products Under New Regulatory Framework
CMS updates Medicare Advantage policy to allow insurance coverage for federally and state-legal CBD products, amid evolving hemp regulatory definitions and market challenges.